Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity Artwork

The BioInsights Podcast

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

The BioInsights Podcast

Formulation and delivery of RNA-based vaccines and therapeutics: addressing outstanding questions around safety and purity

November 06, 2025 • BioInsights • Season 4 • Episode 8

In this interview, Róisin McGuigan, Editor, Nucleic Acid Insights, and Jesse Erasmus, Director of Virology at HDT Bio, discuss current challenges and opportunities in RNA safety, manufacturing, and targeted delivery, and the key ongoing obstacles facing viral and LNP-based delivery modalities.